Bioventus Inc (BVS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating
CCORF Maintains Bioventus(BVS.US) With Buy Rating, Maintains Target Price $12
Express News | Bioventus Inc - Divestiture Reduces Annual Revenue by $50 Million and Adjusted Ebitda by $6 Million
Express News | Bioventus Inc - Expects to Net $20 Million After Fees and Expenses
Express News | Bioventus Inc - Transaction Includes $45 Million Total Cash Consideration